Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

CSE:BNXT - Post Discussion

BioNxt Solutions Inc > The news is out and it is EXCEPTIONAL.
View:
Post by wallpaper2 on Dec 17, 2020 5:50am

The news is out and it is EXCEPTIONAL.

It took long enough to jump thru the hoops in Germany but the game changing news is on Stockwatch and will hopefully reach the world today.  They have reduced the turnaround time for the Gold standard PCR test from hours and days to 25 minutes !!  No specialized equipment necessary.
Comment by gemsearcher2 on Dec 17, 2020 9:09am
Was glad to read your message this morning!..really good news.. wow.. this can be such a huge help to so many people have a great day! WA
Comment by gemsearcher2 on Dec 17, 2020 9:17am
So they now have successful validation so in the next short timeframe and i particularly like this part: : "European regulatory approval and commercial product launch in European markets are planned for Q1 2021." Great!
Comment by Adwari on Dec 17, 2020 9:31am
PCR-based results in 25 minutes. Wonderful. I just hope they seek approval as soon as January 2021.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities